New City, NY, United States of America

Colleen E Evans


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Colleen E Evans: Pioneer in Neuroprotection and Cancer Treatment

Introduction:

Colleen E Evans, a brilliant researcher based in New City, NY, has made significant contributions to the field of neuroprotection and cancer treatment. With a patent for 1,2-dithiolane compounds capable of combating a variety of diseases and conditions, Evans has emerged as a leading figure in the pharmaceutical industry. Let's delve deeper into her journey and notable achievements.

Latest Patents:

Evans' most notable invention is a series of 1,2-dithiolane compounds that have shown promising results in treating various diseases and conditions associated with tyrosine kinases, MAPK signaling pathway kinases, and PI3K/AKT/mTor pathway kinases. These compounds hold immense potential in the realms of neuroprotection, autoimmune diseases, cancer, and other related conditions. By targeting specific kinases like FYN, FLT3, BRAF, and PI3K α/β/γ/δ, Evans's invention opens new avenues for therapeutic advancements.

Career Highlights:

Colleen E Evans is currently associated with Sabila Biosciences LLC, a notable pharmaceutical company that focuses on developing innovative therapies. Her work at Sabila Biosciences has propelled the company's reputation as a frontrunner in the field of neuroprotection and cancer treatment.

Collaborations:

Throughout her professional journey, Evans has had the privilege of working alongside esteemed researchers and scientists. One such collaborator is Tarek Suhayl Mansour, a respected figure in the field of biotechnology. Their collaborative efforts have paved the way for groundbreaking discoveries and patents, fostering advancements in healthcare and pharmaceuticals.

Conclusion:

Colleen E Evans has solidified her position as an influential figure in the field of pharmaceutical research. Her patent for 1,2-dithiolane compounds has opened up new possibilities in the treatment of several diseases and conditions. With ongoing collaborations and continued dedication to scientific innovation, Evans's contributions to the world of neuroprotection and cancer treatment are poised to make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…